Search Within

David B Agus

Formats
  1. Journal Article (18)
  2. Meeting Abstract (8)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (21)
  2. Genitourinary Oncology Service (17)
  3. Solid Tumor Oncology Division (17)
  4. Center for Hematologic Malignancies (5)
  5. GSK Faculty (5)
  6. Hematologic Malignancies, Division of (5)

More Groups

People
  1. Howard Scher (17)
  2. Carlos Cordon-Cardo (12)
  3. Brian Higgins (10)
  4. William Fox (9)
  5. David Golde (7)
  6. Marija Drobnjak (6)

More People

Years
  1. 2004 (1)
  2. 2002 (2)
  3. 2001 (4)
  4. 2000 (9)
  5. 1999 (6)
  6. 1998 (3)

More Years

Publications
  1. Cancer Research (6)
  2. Clinical Cancer Research (4)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (4)
  4. Blood (3)
  5. Journal of Clinical Oncology (2)
  6. Seminars in Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. American Society of Hematology (3)
  3. American Society of Clinical Oncology (2)
  4. Elsevier Inc. (2)
  5. American Society for Clinical Investigation (1)
  6. John Wiley & Sons (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: Recommendations from the Prostate-Specific Antigen Working Group
    Journal Article

    Scher, H. I.; Eisenberger, M.; D'Amico, A. V.; Halabi, S.; Small, E. J.; Morris, M.; Kattan, M. W.; Roach, M.; Kantoff, P.; Pienta, K. J.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts
    Journal Article

    Solit, D. B.; Zheng, F. F.; Drobnjak, M.; Mùˆnster, P. N.; Higgins, B.; Verbel, D.; Heller, G.; Tong, W.; Cordon-Cardo, C.; Agus, D. B.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Vaccination with CD20 peptides induces a biologically active, specific immune response in mice
    Journal Article

    Roberts, W. K.; Livingston, P. O.; Agus, D. B.; Pinilla-Ibarz, J.; Zelenetz, A.; Scheinberg, D. A.
    Blood (2002)

    Fulltext@MSK | Save
  • Functional dissection of transcriptional profiles in androgen-dependent and - independent prostate cancer
    Meeting Abstract

    Amler, L.; Agus, D.; Dracopoli, N.; Scher, H.; Hampton, G.
    Nature Genetics (2001)

    Fulltext@MSK | Save
  • Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke
    Journal Article

    Huang, J.; Agus, D. B.; Winfree, C. J.; Kiss, S.; Mack, W. J.; McTaggart, R. A.; Choudhri, T. F.; Kim, L. J.; Mocco, J.; Pinsky, D. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2001)

    Fulltext@MSK | Save
  • HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer
    Journal Article

    Osman, I.; Scher, H. I.; Drobnjak, M.; Verbel, D.; Morris, M.; Agus, D.; Ross, J. S.; Cordon-Cardo, C.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
    Journal Article

    Butler, L. M.; Webb, Y.; Agus, D. B.; Higgins, B.; Tolentino, T. R.; Kutko, M. C.; LaQuaglia, M. P.; Drobnjak, M.; Cordon-Cardo, C.; Scher, H. I.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Antibody to VEGF slows growth of an androgen-independent xenograft model of prostate cancer
    Meeting Abstract

    Higgins, B.; Fox, W. D.; Scher, H. I.; Maiese, K. M.; Drobnjak, M.; Cordon-Cardo, C.; Agus, D. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Anti-tumor activity of Apo2 ligand (TRAIL) in androgen-dependent and androgen-independent human prostate cancer xenograft models
    Meeting Abstract

    Maiese, K. M.; Scher, H. I.; Fox, W. D.; Higgins, B.; Drobnjak, M.; Cordon-Cardo, C.; Agus, D. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Hybrid polar inhibitors of histone deacetylase suppress the growth of the CWR22 human prostate cancer xenograft
    Meeting Abstract

    Butler, L. M.; Higgins, B.; Fox, W. D.; Agus, D. B.; Cordon-Cardo, C.; Scher, H. I.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save